scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0002-9149(96)00532-2 |
P698 | PubMed publication ID | 8916486 |
P2093 | author name string | A Mathur | |
S P Jain | |||
G S Roubin | |||
J S Yadav | |||
L S Dean | |||
M W Liu | |||
J M Parks | |||
C M Goods | |||
K F al-Shaibi | |||
S S Iyer | |||
P2860 | cites work | Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance | Q28235915 |
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke | Q34462070 | ||
A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group | Q34540010 | ||
Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group | Q42064869 | ||
Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty | Q44290037 | ||
Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome | Q70568674 | ||
A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation | Q70866645 | ||
Utilization of the coronary balloon-expandable coil stent without anticoagulation or intravascular ultrasound | Q71089485 | ||
Sizing the Gianturco-Roubin coronary flexible coil stent | Q72790728 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | aspirin | Q18216 |
P304 | page(s) | 1042-1044 | |
P577 | publication date | 1996-11-01 | |
P1433 | published in | American Journal of Cardiology | Q2208417 |
P1476 | title | Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting | |
P478 | volume | 78 |
Q77371764 | Abciximab administration and outcome after intracoronary stent implantation |
Q33805244 | Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents |
Q35368874 | Antiplatelet treatment with cilostazol after stent implantation. |
Q48294670 | Aortic Source of Brain Embolism |
Q28192340 | Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study |
Q33329240 | Aspirin and ticlopidine after routine coronary stenting: the gold standard as of 1999. |
Q74562161 | Clinical outcome at six months of coronary stenting followed by ticlopidine monotherapy |
Q73250221 | Clopidogrel versus ticlopidine after intracoronary stent placement |
Q33329991 | Comparison of cilostazol versus ticlopidine therapy after stent implantation |
Q28194785 | Comparison of clopidogrel versus ticlopidine for prevention of minor myocardial injury after elective coronary stenting |
Q73022264 | Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting |
Q73014651 | Effects of cilostazol on angiographic restenosis after coronary stent placement |
Q30305538 | Management of Acute Ischemic Coronary Syndromes: The Present and Future |
Q28182051 | New polycyclic pyrimidine derivatives with antiplatelet in vitro activity: synthesis and pharmacological screening |
Q38008828 | Platelet adenosine diphosphate receptor antagonists: ticlopidine to ticagrelor-a long continuing journey |
Q33770499 | Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications. |
Q28186141 | Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures |
Q28186354 | The role of adenosine 5'-diphosphate receptor blockade in patients with cardiovascular disease |
Q33588350 | Update in internal medicine |
Q94558111 | Value of Antiplatelet Therapy in Preventing Thrombotic Events in Generalized Vascular Disease |
Search more.